| 10X GENOMICS DL -,00001 |
| USA |
| Gesundheit |
| US88025U1097 / A2PPQJ |
| 1KJ (Frankfurt) / TXG (NASDAQ) |
| FRA:1KJ, ETR:1KJ, 1KJ:GR, NASDAQ:TXG |
| - |
| https://www.10xgenomics.c.. |
|
10x Genomics Inc. Class A Common Stock represents ownership in 10x Genomics, a life science technology company focused on products that help researchers study biology at high resolution. The company develops integrated instruments, consumables, and s..
>Volltext.. |
| 8661.11 Mio. EUR |
| 8246.46 Mio. EUR |
| 542.31 Mio. EUR |
| -37.93 Mio. EUR |
| -66.04 Mio. EUR |
| -0.52 EUR |
| 69.27 Mio. EUR |
| 441.74 Mio. EUR |
| 111.72 Mio. EUR |
| 4.66 |
| -1.26% |
| 8.41% |
| - |
| - |
| - |
| 5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 9.371.835 Euro. |
| 10X GENOMICS, 10XGENOMICS |
| 25.09.26 |
|